Read More Analyst Ratings Downgrades News Price Target B of A Securities Downgrades Azul to Underperform, Raises Price Target to $20.8 By vishwanath@benzinga.com Today, 9:23 PM B of A Securities analyst Murilo Freiberger downgrades Azul (NYSE:AZUL) from Neutral to Underperform and raises the price target from $15 to $20.8. AZUL
Read More Analyst Ratings News Price Target Citigroup Maintains Neutral on Peloton Interactive, Lowers Price Target to $38 By Benzinga Newsdesk Today, 9:23 PM Citigroup analyst Jason Bazinet maintains Peloton Interactive (NASDAQ:PTON) with a Neutral and lowers the price target from $55 to $38. PTON
Read More Biotech FDA General Management News Altamira Therapeutics Provides Year-End 2022 Business Update; Promoted Covadonga Pañeda, From Chief Development Officer To Chief Operating Officer By Benzinga Newsdesk Today, 9:23 PM Altamira Therapeutics Provides Year-End 2022 Business Update Strategic BentrioTM partnering or divestiture process enters decisive phase Partnering or divestiture process for inner ear CYTO
Read More Movers News Short Sellers Trading Ideas Tattooed Chef Shares Move Lower; The Bear Cave Issues Report Titled ‘Problems at Tattooed Chef’ By Benzinga Newsdesk Today, 9:23 PM https://thebearcave.substack.com/p/problems-at-tattooed-chef-ttcf TTCF